TCL Archive After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant June 11, 2014
TCL Archive “Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged” January 23, 1976
TCL Archive In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte March 8, 1991
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
